563 related articles for article (PubMed ID: 11346913)
1. [Dyslipidemia in diabetes mellitus].
Niemeijer-Kanters SD; Banga JD; Erkelens DW
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Wolffenbuttel BH; Huijberts MS
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
Broedl UC; Lehrke M; Parhofer KG
MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
[No Abstract] [Full Text] [Related]
6. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
7. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Nicholls SJ; Lundman P; Tardif JC
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
[TBL] [Abstract][Full Text] [Related]
8. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.
Hobbs FD
Int J Cardiol; 2006 Jun; 110(2):137-45. PubMed ID: 16289373
[TBL] [Abstract][Full Text] [Related]
9. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
Gouni-Berthold I; Krone W
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
11. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
Betteridge J
Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials and lipid guidelines for type II diabetes.
Prisant LM
J Clin Pharmacol; 2004 Apr; 44(4):423-30. PubMed ID: 15051751
[TBL] [Abstract][Full Text] [Related]
13. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
14. Managing dyslipidemia in adults with diabetes.
Haffner SM
Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
[No Abstract] [Full Text] [Related]
15. [Diabetic dyslipoproteinemia: beyond LDL].
Merkel M
Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
[TBL] [Abstract][Full Text] [Related]
16. Lipid disorders in type 2 diabetes.
Braun LT
Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
[TBL] [Abstract][Full Text] [Related]
17. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
Pados G; Audikovszky M
Orv Hetil; 2003 Mar; 144(12):557-61. PubMed ID: 12723526
[TBL] [Abstract][Full Text] [Related]
18. The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?
Kendall DM
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):27-48. PubMed ID: 15752920
[TBL] [Abstract][Full Text] [Related]
19. Lipid abnormalities in insulin resistant states.
Watson KE; Horowitz BN; Matson G
Rev Cardiovasc Med; 2003; 4(4):228-36. PubMed ID: 14668690
[TBL] [Abstract][Full Text] [Related]
20. Management of dyslipidemia in diabetes.
Solano MP; Goldberg RB
Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
